avapritinib

FDA Action Alert: Blueprint, Orphazyme and Eton
BioSpace
Mon, 06/14/21 - 10:52 am
FDA
Blueprint Medicines
avapritinib
Orphazyme
arimoclomol
Eton Pharmaceuticals
Blueprint hits goal in midphase rare disease trial, teeing up pivotal study
Fierce Biotech
Mon, 03/16/20 - 11:52 pm
Blueprint Medicines
avapritinib
clinical trials
systemic mastocytosis
Blueprint posts 'impressive' data for lead candidate, but investor response tepid
Biopharma Dive
Fri, 11/16/18 - 08:06 pm
Blueprint Medicines
clinical trials
avapritinib
gastrointestinal cancer